Key Record Dates
ClinicalTrials.gov Identifier: | NCT05213104 |
---|---|
Brief Title: | Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia (AFLOAT) |
First Submitted : | December 20, 2021 |
First Submitted that Met QC Criteria : | January 14, 2022 |
First Posted : | January 28, 2022 |
Last Update Submitted that Met QC Criteria : | September 6, 2022 |
Last Update Posted : | September 7, 2022 |